Home » Topics » BioWorld Science

BioWorld Science
RSS

Merck & Co. divulges new IDO1 inhibitors

March 5, 2020

Gudui Biopharma Technology identifies new compounds for stroke

March 5, 2020

Forma Therapeutics patents HDAC6 inhibitors

March 5, 2020

FGL1 as a novel therapeutic target in obesity

March 5, 2020

Phase III data reported from ESCAPE-NA1 study of nerinetide

March 5, 2020

Nascent Biotech to evaluate the potential of pritumumab as therapy for COVID-19

March 5, 2020

First patient dosed in phase I study of HLX-55

March 5, 2020

FDA clears IND application for AIM-001

March 5, 2020

Epigenetic therapy disrupts premetastatic microenvironment

March 5, 2020

New phase II study investigates Telomelysin and radiotherapy for locally advanced esophageal cancer

March 4, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...